Allakos

BiotechnologySeries BRedwood City, USallakos.com

Latest round

Series B

Last raised

Nov 2017

Total raised

$142M

Investors

11

About Allakos

Established in 2012 and based in California, US, Allakos Inc. is a biotechnology company that develops antibody-based therapeutics to treat inflammatory and various diseases.

Who invested in Allakos

11 investors across 3 rounds

See all investors in Allakos

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Nov 30, 2017

    Amount

    $100M

    Investors

    Locked

  2. Series A

    Sep 30, 2014

    Amount

    $10M

    Investors

    Locked

  3. Series A

    Dec 17, 2012

    Amount

    $32M

    Investors

    Locked

Questions about Allakos

Who invested in Allakos?

Allakos has 11 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Allakos raised?

Allakos has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did Allakos last raise money?

Allakos's most recent round on record is a Series B, in Nov 2017.

What does Allakos do?

Established in 2012 and based in California, US, Allakos Inc.

Where is Allakos headquartered?

Allakos is headquartered in Redwood City, US.

Which VCs invest in companies like Allakos?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Allakos's stage. Their profiles are linked below.

Raising like Allakos? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.